You didn't talk to him. I saw your tweet yesterday. Please read that article from my previous post.
From the article:
Dara is currently engaged in dialogue with the FDA on ODD. According to management, they are in round three of responding to questions from the agency. The company filed a response to the FDA on August 8, 2013. If timelines hold, a decision from the FDA should be made in October or November 2013.